...
首页> 外文期刊>Experimental Neurology >The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain
【24h】

The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain

机译:帕金森氏病的MPTP神经毒性病变模型激活小鼠脑中的载脂蛋白E级联反应

获取原文
获取原文并翻译 | 示例

摘要

Apolipoprotein E (apoE) is recognized as a key actor in brain remodeling. It has been shown to increase after peripheral and central injury, to modulate reparative capacity in neurodegenerative conditions like Alzheimer's disease (AD) and to be associated with a number of other neurodegenerative diseases. This particular function of apoE has been postulated to underlie the robust association with risk and age at onset of AD. ApoE associations studies with Parkinson's disease (PD), the second most prevalent neurodegenerative disease, have generated contradictory results but associations with age at onset and dementia in PD stand out. We investigate here whether apoE is involved in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced degeneration that models PD-like deafferentation of the striatum in the mouse and participates in compensatory reinnervation mechanisms. We examined the modifications in gene expression and protein levels of apoE and its key receptors, the low density lipoprotein receptor (LDLR) and the LDLR-related protein (LRP), as well as the reactive astrocyte marker glial fibrillary acidic protein (GFAP) in different brain structures throughout the degenerative and reactive regenerative period. In the striatum, upregulations of GFAP, apoE and LRP mRNAs at 1. day post-treatment were associated with marked decreases in dopamine (DA) levels, loss in tyrosine hydroxylase protein content, as well as to a compensatory increase in dopaminergic metabolism. Subsequent return to near control levels coincided with indications of reinnervation in the striatum: all consistent with a role of apoE during the degenerative process and regenerative period. We also found that this cascade was activated in the hippocampus and more so than in the striatum, with a particular contribution of LDLR expression. The hippocampal activation did not correlate with substantial neurochemical reductions but appears to reflect local subtle alteration of DA metabolism and the regulation of plasticity-related event in this structure. This study provides first evidence of an activation of the apoE/apoE receptors cascade in a mouse model of PD, specifically in the MPTP-induced deafferentation of the striatum. Results are also quite consistent with the postulated role of apoE in brain repair but, raise the issue of possible lesion- and region-specific alterations in gene expression.
机译:载脂蛋白E(apoE)被认为是大脑重塑的关键角色。已经表明,在周围和中枢损伤后,其增加,在诸如阿尔茨海默氏病(AD)的神经退行性疾病中调节修复能力,并且与许多其他神经退行性疾病相关。假定apoE的这一特殊功能是与AD发病的风险和年龄密切相关的基础。 ApoE与帕金森氏病(PD)(第二大流行的神经退行性疾病)的关联研究产生了矛盾的结果,但与PD发病年龄和痴呆症的关联突出。我们在这里调查apoE是否参与对1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的变性的反应,该变性模拟小鼠纹状体的PD样脱除咖啡因并参与代偿性神经支配机制。我们检查了apoE及其关键受体,低密度脂蛋白受体(LDLR)和LDLR相关蛋白(LRP)以及反应性星形胶质细胞标记神经胶质纤维酸性蛋白(GFAP)的基因表达和蛋白水平的修饰。整个退化和反应性再生期间的大脑结构都不同。在纹状体中,治疗后第1天GFAP,apoE和LRP mRNA的上调与多巴胺(DA)水平显着降低,酪氨酸羟化酶蛋白含量降低以及多巴胺能代谢的补偿性升高有关。随后恢复到接近控制的水平,与纹状体中神经支配的迹象相吻合:所有这些都与在退化过程和再生期中apoE的作用一致。我们还发现,该级联在海马中被激活,而不是在纹状体中被激活,尤其是在LDLR表达方面。海马激活与神经化学物质的大量减少无关,但似乎反映了DA代谢的局部细微变化以及该结构中可塑性相关事件的调节。这项研究提供了PD小鼠模型中apoE / apoE受体级联激活的第一个证据,特别是在MPTP诱导的纹状体脱咖啡因作用中。结果也与假定的apoE在脑修复中的作用非常一致,但提出了基因表达中可能存在的病变和区域特异性改变的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号